Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1195 of 5804
-
New drug shows promise for rare bone and soft tissue cancers
Disease control Recruiting nowThis is a single-center, open-label phase II study of QL1706 for the treatment of advanced bone and soft tissue sarcomas.The study includes screening period, treatment period and follow-up period. Subjects will receive QL1706 5mg/kg iv every 3 weeks until disease progression or i…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug trial aims to tame chronic lung infections
Disease control Recruiting nowThis is a phase III, single-arm, open-label, multicenter study to assess the safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
AI chatbot aims to boost HPV vaccination in young women
Prevention Not yet recruitingThe goal of this clinical trial is to learn if a chatbot powered by artificial intelligence works to improve HPV vaccination among females aged 15 to 26 in China. A randomized controlled trial and implementation science study will be conducted targeting females as participants. T…
Phase: NA • Sponsor: Fudan University • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
New drug tulisokibart aims to ease back pain and stiffness in ankylosing spondylitis
Disease control Recruiting nowResearchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and inflammation (swelling) in the spine and joints in the pelvis (hip bone). Radiographic means the damage it causes can be s…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New pill could clear psoriasis skin in weeks
Disease control Not yet recruitingThe purpose of this study is to assess the efficacy and safety of HSK44459 administered orally for moderate to severe plaque psoriasis in adults.
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:57 UTC
-
Back pain breakthrough? own cells injected into damaged discs
Disease control Recruiting nowThis is an open-label, single-center Phase I/II clinical trial investigating the safety and efficacy of autologous nucleus pulposus cells (aNPC) in patients with disc degeneration. Eligible participants are those assessed by the principal investigator to have disc herniation suit…
Phase: PHASE1, PHASE2 • Sponsor: ASTEROGENE Biomedical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Experimental combo targets stomach cancer fluid after other treatments fail
Disease control Not yet recruitingThis study is a prospective, non-randomized, dual-cohort Phase II clinical trial designed to explore the efficacy and safety of radiotherapy combined with intraperitoneal injection of Recombinant Mutant Human Tumor Necrosis Factor (rmhTNF-NC) and tislelizumab in the treatment of …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could immune cells tame advanced bladder cancer? early trial aims to find out
Disease control Not yet recruitingWe plan to enroll 20-29 patients with advanced bladder cancer to undergo T-cell therapy. Each treatment cycle consists of three T-cell infusions, with two cycles planned per patient. Each cycle will include imaging studies, laboratory tests, and vital sign monitoring to evaluate …
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a tiny brain zapper ease gulf war Veterans' pain?
Symptom relief Recruiting nowThe main goal of the proposed study is to critically evaluate a nonpharmacological and readily available therapy, cranial electrical stimulation (CES) using Alpha-Stim™, and to discover the brain function mechanisms underlying Gulf War Illness-related Headache and Pain (GWI-HAP) …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Experimental cell therapy targets tough blood cancers and anemia
Disease control Recruiting nowThe goal of this clinical study is to evaluate the safety and efficacy of GT801 injection in adult patients with relapsed/refractory CD19-positive B-cell hematologic malignancies and autoimmune hemolytic anemia. Interim analysis conducted when 2 patients complete primary endpoint…
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for stubborn nerve disorder: drug combo shows promise
Disease control OngoingThis multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of Telitacicept in patients with refractory chronic inflammatory demyelinating polyneuropathy (CIDP). Eligible patients will be randomly assigned to receive either conventional therapy alone o…
Phase: NA • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a sensory room help traumatized teens regain control?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if Sensory motor arousal regulation treatment (SMART) works better than treatment as usual (TAU) to treat youth 7-17 years with complex trauma histories and self-regulation difficulties. The study also will investigate which patients wi…
Phase: NA • Sponsor: Vestre Viken Hospital Trust • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can a daily pill preserve erections after rectal cancer therapy?
Disease control Recruiting nowThis study aims to evaluate the efficacy of erectile rehabilitation with Sildenafil, in men treated with neoadjuvant proctectomy and radiotherapy for rectal cancer, in preventing long-term erectile dysfunction at 12 months post-operatively.
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New radiation technique aims to zap prostate cancer with fewer side effects
Disease control Recruiting nowThe goal of this clinical trial is to evaluate if adaptive stereotactic body radiation therapy (SBRT) is a safe and effective way to treat prostate cancer in adults. It will assess the safety profile of adaptive SBRT over time. The main questions this trial aims to answer are: …
Phase: NA • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Amniotic membrane grafts show promise for stubborn wounds
Disease control OngoingThis observational study will evaluate the real-world effectiveness of four amniotic membrane-based products (Zenith™, Orion™, SurGraft FT™, Complete ACA™) in addition to standard care, compared with standard care alone. The study will use complete electronic health records (EHR)…
Sponsor: Legacy Medical Consultants • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can telehealth bring HIV prevention to rural drug users?
Prevention ENROLLING_BY_INVITATIONThe expansion of HIV pre-exposure prophylaxis (PrEP) care has been endorsed as a key strategy for reducing new HIV infections, however, PrEP trials among people who inject drugs (PWID) are rare and uptake of PrEP has been minimal, most notably in rural areas. Structural barriers …
Phase: NA • Sponsor: Hilary L Surratt, PhD • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New drug cocktail aims to shrink colon tumors before surgery
Disease control Not yet recruitingThis is a single-arm, exploratory study enrolling participants with resectable stage III pMMR/MSS colon cancer. Eligible participants who provide written informed consent will receive four cycles of neoadjuvant treatment with iparomlimab and tuvonralimab (QL1706) plus XELOX regim…
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 26, 2026 14:11 UTC
-
New eczema ointment shows promise in early trial
Disease control CompletedThis study is ongoing to explore the efficacy and safety of different strengths of RSS0393 ointment in adults with atopic dermatitis
Phase: PHASE2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug livmarli tracked for Long-Term safety in kids with rare liver disorders
Disease control Recruiting nowIn patients with Alagille syndrome (ALGS), the key objectives are to evaluate the tolerability, long-term safety (including possible liver toxicity) and long-term efficacy of Livmarli treatment. In patients with Progressive Familial Intrahepatic Cholestasis (PFIC), the key objec…
Phase: PHASE4 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo therapy aims to extend life for elderly esophageal cancer patients
Disease control Not yet recruitingThis study is a single-arm, multicenter clinical trial evaluating the efficacy and safety of radiotherapy combined with TAS-102 monotherapy in elderly patients with locally advanced esophageal cancer. Treatment Phase: The treatment phase is divided into a Phase I stage and a Pha…
Phase: PHASE1, PHASE2 • Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC